Zenith Drugs Limited
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specializing in manufacturing and trading medicines, including generic drugs.
What Zenith files
- Others31
- Updates17
- Important12
- Board Meeting10
- Results3
- Dividend/Bonus1
The Exchange had sought clarification from Zenith Drugs Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Zenith Drugs Limited has announced a board meeting on May 29, 2025, to consider and approve the financial results for the quarter and half-year ended March 31, 2025. The audited financial results were approved and authorized for signing by Director Bhupesh Soni and CFO Neeraj Pandey. No financial metrics or...
**Zenith Drugs Limited Financial Summary** Zenith Drugs Limited has reported standalone financial results for the half year ended September 30, 2024. Total revenue reached ₹68.56 crore, representing a slight decrease of 1.33% compared to ₹69.48 crore in the same period last year. This decline may be attributed to increased competition...